TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›ALAB›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

Astera Labs, Inc. (ALAB) financials

Income statement

Astera Labs, Inc. (ALAB) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$79.9M$116M$396M$853M
Revenue growth—45.0%242.2%115.1%
Gross profit$58.7M$79.8M$303M$645M
Gross margin73.5%68.9%76.4%75.7%
Operating income-$60.2M-$29.5M-$116M$173M
Operating margin-75.4%-25.5%-29.3%20.3%
Net income-$58.3M-$26.3M-$83.4M$219M
Net margin-73.0%-22.7%-21.1%25.7%
EPS (diluted)-$1.71-$0.71-$0.64$1.22

Cash flow

Astera Labs, Inc. (ALAB) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow-$35.9M-$12.7M$137M$319M
Capital expenditures$3.87M$2.76M$34.2M$37.5M
Free cash flow-$39.8M-$15.5M$102M$282M
Share buybacks$313K$210K$1.07M$0.00

Balance sheet

Astera Labs, Inc. (ALAB) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$76.1M$45.1M$79.6M$168M
Total assets—$196M$1.05B$1.53B
Total liabilities—$38.9M$89.7M$168M
Shareholders' equity-$85.3M-$97.7M$965M$1.36B
Retained earnings—-$125M-$209M$10.3M
Shares (wtd avg diluted)34.2M37.1M131M180M

Every figure is extracted from Astera Labs, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Astera Labs, Inc.'s annual revenue?
Astera Labs, Inc. (ALAB) reported $853M of revenue for fiscal year 2025 — up 115.1% from $396M in FY2024, per its annual report filed with the SEC.
Is Astera Labs, Inc. profitable?
Yes — ALAB earned $219M of net income in FY2025, a 25.7% net margin, per SEC filings.
What is Astera Labs, Inc.'s free cash flow?
$282M in FY2025 (operating cash flow $319M minus $37.5M of capital expenditures), from the SEC cash-flow statement.
Does ALAB pay a dividend?
Astera Labs, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full ALAB analysis — verdict, score & filings →Is ALAB a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.